Bull case
MMM would need investors to value it at roughly 33x earnings — about 15x more generous than today's 18x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where MMM stock could go
MMM would need investors to value it at roughly 33x earnings — about 15x more generous than today's 18x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 25x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 3x multiple contraction could push MMM down roughly 15% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

3M is a diversified industrial conglomerate that manufactures thousands of industrial, consumer, and healthcare products — from Post-it Notes and Scotch tape to medical supplies and industrial adhesives. It generates revenue through four main segments: Safety & Industrial (~35%), Transportation & Electronics (~25%), Health Care (~25%), and Consumer (~15%). The company's competitive moat lies in its massive patent portfolio — over 60,000 patents — and its deep expertise in materials science that enables it to create innovative products across diverse markets.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $2.16/$2.01 | +7.5% | $6.3B/$6.1B | +3.7% |
| Q4 2025 | $2.19/$2.07 | +5.8% | $6.5B/$6.2B | +4.3% |
| Q1 2026 | $1.83/$1.80 | +1.7% | $6.0B/$6.0B | -0.1% |
| Q2 2026 | $2.14/$1.98 | +8.1% | $6.0B/$6.0B | -0.1% |
MMM beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $186 — implies +15.5% from today's price.
| Metric | MMM | S&P 500 | Industrials | 5Y Avg MMM |
|---|---|---|---|---|
| Forward PE | 18.5x | 18.8x | 21.2x-13% | — |
| Trailing PE | 26.8x | 24.4x | 25.6x | 17.1x+57% |
| PEG Ratio | — | 1.66x | 1.65x | — |
| EV/EBITDA | 16.8x | 15.2x+11% | 13.9x+21% | 12.8x+31% |
| Price/FCF | 60.0x | 20.7x+190% | 20.0x+199% | 42.6x+41% |
| Price/Sales | 3.4x | 3.1x | 1.6x+115% | 2.5x+34% |
| Dividend Yield | 1.36% | 1.91% | 1.21% | 4.11% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolMMM generates $2.1B in free cash flow at a 8.2% margin — 28.1% ROIC signals a durable competitive advantage · returns 7.1% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~3.7 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Increased legal and regulatory risks from PFAS and Combat Arms settlements, which could lead to significant financial liabilities.
Uncertainty around the Solventum spin-off during a turbulent global environment, which may impact financial stability and investor confidence.
Heightened operational and market risks due to a challenging global economic environment, affecting performance and growth.
Increased attention on AI, cybersecurity, and compliance risks, which could expose the company to vulnerabilities and regulatory scrutiny.
Dependence on well-known consumer brands like Post-it and Scotch Tape, which may face competitive pressures or shifting consumer preferences.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
3M's diverse range of products, from abrasives to futuristic materials, supports seamless operations and drives demand across industries.
Well-known consumer brands like Scotch Tape, Post-it notes, and Nexcare bandages enhance 3M's market presence and customer loyalty.
3M's consistent dividend payments and significant stock repurchases highlight its commitment to shareholder returns and financial stability.
3M leverages science and technology to improve lives worldwide, fostering innovation and progress across communities.
With roots dating back to 1902, 3M's long-standing presence and adaptability underscore its enduring market relevance.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
MMM MMM 3M Company | $83.8B | 18.5x | +0.1% | 11.1% | Hold | +3.8% |
HON HON Honeywell International Inc. | $145.1B | 21.8x | +5.7% | 11.2% | Buy | +9.0% |
EMR EMR Emerson Electric Co. | $84.4B | 23.2x | +3.4% | 13.3% | Buy | +7.7% |
ITW ITW Illinois Tool Works Inc. | $76.1B | 23.4x | +2.8% | 19.3% | Hold | +2.7% |
ETN ETN Eaton Corporation plc | $163.8B | 31.6x | +10.7% | 14.0% | Buy | -1.2% |
PH PH Parker-Hannifin Corporation | $120.3B | 30.5x | +3.1% | 16.6% | Buy | +9.9% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
MMM returns capital mainly through $4.8B/year in buybacks (5.7% buyback yield), with a modest 1.36% dividend — combining for 7.1% total shareholder yield.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.56 | — | — | — |
| 2025 | $2.92 | -13.2% | 5.6% | 6.9% |
| 2024 | $3.36 | -33.0% | 2.5% | 5.3% |
| 2023 | $5.02 | +0.7% | 0.1% | 6.6% |
| 2022 | $4.98 | +0.7% | 2.6% | 8.5% |
Common questions answered from live analyst data and company financials.
3M Company (MMM) is rated Hold by Wall Street analysts as of 2026. Of 33 analysts covering the stock, 15 rate it Buy or Strong Buy, 17 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $167, implying +3.8% from the current price of $161. The bear case scenario is $137 and the bull case is $287.
The Wall Street consensus price target for MMM is $167 based on 33 analyst estimates. The high-end target is $190 (+18.3% from today), and the low-end target is $136 (-15.3%). The base case model target is $218.
MMM trades at 18.5x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals slightly cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for MMM in 2026 are: (1) Legal and regulatory issues — Increased legal and regulatory risks from PFAS and Combat Arms settlements, which could lead to significant financial liabilities. (2) Spin-off uncertainty — Uncertainty around the Solventum spin-off during a turbulent global environment, which may impact financial stability and investor confidence. (3) Operational and market risks — Heightened operational and market risks due to a challenging global economic environment, affecting performance and growth. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates MMM will report consensus revenue of $25.0B (+0.1% year-over-year) and EPS of $7.27 (+39.0% year-over-year) for the upcoming fiscal year. The following year, analysts project $25.7B in revenue.
3M Company is expected to report its next earnings on approximately 2026-07-17. Consensus expects EPS of $2.24 and revenue of $6.4B. Over recent quarters, MMM has beaten EPS estimates 100% of the time.
3M Company (MMM) generated $2.1B in free cash flow over the trailing twelve months — a free cash flow margin of 8.2%. MMM returns capital to shareholders through dividends (1.4% yield) and share repurchases ($4.8B TTM).